Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients
Raphaël Aitmehdi, Laurent Arnaud, C. Francès, Patricia Senet, J.‐B. Monfort, T. De Risi-Pugliese, A. Barbaud, Fleur Cohen‐Aubart, Julien Haroche, M. Pha, Miguel Hie, Véronique Le Guern, N. Costedoat‐Chalumeau, A. Mékinian, O. Fain, Alexis Mathian, Zahir Amoura, François Chasset
Topics & Concepts
MedicineLenalidomideDermatologySystemic lupus erythematosusCutaneous Lupus ErythematosusLupus erythematosusInternal medicineRefractory (planetary science)Subacute cutaneous lupus erythematosusHydroxychloroquineRetrospective cohort studyConnective tissue diseaseDiseaseAutoimmune diseaseImmunologyMultiple myelomaAstrobiologyAntibodyInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)PhysicsT-cell and B-cell ImmunologySystemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies Research